20485-38-5

Basic information

• Product Name: Acetic acid, 2-(4-aminophenoxy)-, ethyl ester
• Synonyms: Acetic acid, 2-(4-aminophenoxy)-, ethyl ester;(4-Aminophenoxy)acetic acid ethyl ester;ethyl 2-(4-aminophenoxy)acetate
• CAS NO: 20485-38-5
• Molecular Formula: C₁₀H₁₃NO₃
• Molecular Weight: 195.22
• Mol File: 20485-38-5.mol
• Article Data: 19

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Acetic acid, 2-(4-aminophenoxy)-, ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Acetic acid, 2-(4-aminophenoxy)-, ethyl ester(20485-38-5)
• EPA Substance Registry System: Acetic acid, 2-(4-aminophenoxy)-, ethyl ester(20485-38-5)

Safety Data

• Hazardous Substances Data: 20485-38-5(Hazardous Substances Data)

Upstream product

• 100-02-7 4-nitro-phenol 
• 105-36-2 ethyl bromoacetate 
• 19786-48-2 methyl 2-(4-nitrophenoxy)acetate 
• 19076-89-2 ethyl 4-nitrophenoxyacetate 
• 123-30-8 4-amino-phenol 
• 105-39-5 chloroacetic acid ethyl ester 
• 2298-36-4 4-aminophenoxyacetic acid 

Downstream Products

• 103790-27-8 N-[4-(ethoxycarbonylmethoxy)phenyl]methanesulfonamide 
• 72131-56-7 4-(benzenesulphonylamino)-phenoxyacetic acid 
• 1616380-90-5 ethyl 2-(4-((4-((3-acrylamidophenyl)amino)-5-fluoropyrimidin-2-yl)amino)phenoxy)acetate 
• 1616380-27-8 2-(4-((4-((3-acrylamidophenyl)amino)-5-fluoropyrimidin-2-yl)amino)phenoxy)acetic acid 
• 1310744-79-6 (R)-2-(3-(((4-(carboxymethoxy)phenyl)amino)methyl)benzamido)pentanedioic acid 
• 1310744-78-5 (R)-dimethyl 2-(3-(((4-(2-ethoxy-2-oxoethoxy)phenyl)amino)methyl)benzamido)pentanedioate 
• 1161863-81-5 C₂₀H₁₈N₂O₄ 
• 1078736-58-9 (R)-{4-[{2-[3-tert-butoxycarbonylamino-4-(2,4,5-trifluorophenyl)butyryl]-3,4-dihydro-2H-pyrazole-3-carbonyl}amino]phenoxy}acetic acid ethyl ester 

Relevant articles and documents

Synthesis, molecular docking, dynamic simulation and pharmacological characterization of potent multifunctional agent (dual GPR40-PPARγ agonist) for the treatment of experimental type 2 diabetes

The current manuscript describes two molecules that were designed against PPARγ and GPR40 receptors. The preparation of the compounds was carried out following a synthetic route of multiple steps. Then, the mRNA expression levels of PPARγ, GLUT4, and GPR4

GK and PPAR dual agonist activity aryl urea derivatives

The invention discloses a novel arylurea derivative, its preparation method, pharmaceutical composition and application. Specifically, the invention relates to an arylurea derivative as shown in the general formula I, its medicinal salt, a preparation met

2,4-Pyrimidinediamine Compounds and Their Uses

The present invention provides 2,4-pyrimidinediamine compounds that inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators, intermediates and methods of synthesizing the compounds and methods of using the compounds in a variety of contexts, including in the treatment and prevention of diseases characterized by, caused by or associated with the release of chemical mediators via degranulation and other processes effected by activation of the IgE and/or IgG receptor signaling cascades.